

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleobase biosynthetic process (GO:0046112) | 4.91594821 |
| 2 | purine nucleobase biosynthetic process (GO:0009113) | 4.73910910 |
| 3 | pore complex assembly (GO:0046931) | 4.48744290 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.46752261 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 4.39225788 |
| 6 | regulation of translational termination (GO:0006449) | 4.27614938 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.26721226 |
| 8 | non-recombinational repair (GO:0000726) | 4.26720511 |
| 9 | double-strand break repair via nonhomologous end joining (GO:0006303) | 4.26720511 |
| 10 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.20836207 |
| 11 | histone arginine methylation (GO:0034969) | 4.14903453 |
| 12 | IMP biosynthetic process (GO:0006188) | 4.10097767 |
| 13 | ribosome assembly (GO:0042255) | 4.08453187 |
| 14 | nuclear pore organization (GO:0006999) | 4.07405276 |
| 15 | cullin deneddylation (GO:0010388) | 3.97115097 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 3.95915731 |
| 17 | mitotic metaphase plate congression (GO:0007080) | 3.94635846 |
| 18 | chaperone-mediated protein complex assembly (GO:0051131) | 3.85244066 |
| 19 | peptidyl-arginine N-methylation (GO:0035246) | 3.83358903 |
| 20 | peptidyl-arginine methylation (GO:0018216) | 3.83358903 |
| 21 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.77378739 |
| 22 | protein localization to chromosome, centromeric region (GO:0071459) | 3.76698737 |
| 23 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.72999707 |
| 24 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.72999707 |
| 25 | protein deneddylation (GO:0000338) | 3.68942016 |
| 26 | DNA ligation (GO:0006266) | 3.68673728 |
| 27 | regulation of centriole replication (GO:0046599) | 3.67156679 |
| 28 | establishment of viral latency (GO:0019043) | 3.65422358 |
| 29 | ribosome biogenesis (GO:0042254) | 3.64931111 |
| 30 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.63944231 |
| 31 | mitotic nuclear envelope disassembly (GO:0007077) | 3.59712049 |
| 32 | sister chromatid segregation (GO:0000819) | 3.57614163 |
| 33 | DNA replication initiation (GO:0006270) | 3.57016105 |
| 34 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.55196272 |
| 35 | IMP metabolic process (GO:0046040) | 3.55192144 |
| 36 | nuclear pore complex assembly (GO:0051292) | 3.53632876 |
| 37 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.53206478 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.53036349 |
| 39 | nuclear envelope disassembly (GO:0051081) | 3.52243165 |
| 40 | membrane disassembly (GO:0030397) | 3.52243165 |
| 41 | folic acid metabolic process (GO:0046655) | 3.50563450 |
| 42 | proteasome assembly (GO:0043248) | 3.47613854 |
| 43 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.46827860 |
| 44 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.45771725 |
| 45 | Golgi transport vesicle coating (GO:0048200) | 3.45398471 |
| 46 | COPI coating of Golgi vesicle (GO:0048205) | 3.45398471 |
| 47 | regulation of chromosome segregation (GO:0051983) | 3.42608871 |
| 48 | ribonucleoprotein complex disassembly (GO:0032988) | 3.39350089 |
| 49 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.38301121 |
| 50 | paraxial mesoderm development (GO:0048339) | 3.37534944 |
| 51 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.37432565 |
| 52 | tRNA aminoacylation for protein translation (GO:0006418) | 3.34267127 |
| 53 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.33892833 |
| 54 | protein localization to kinetochore (GO:0034501) | 3.33230051 |
| 55 | metaphase plate congression (GO:0051310) | 3.31110391 |
| 56 | amino acid activation (GO:0043038) | 3.30877709 |
| 57 | tRNA aminoacylation (GO:0043039) | 3.30877709 |
| 58 | regulation of helicase activity (GO:0051095) | 3.29123496 |
| 59 | DNA double-strand break processing (GO:0000729) | 3.28979963 |
| 60 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.26345405 |
| 61 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.26345405 |
| 62 | regulation of sister chromatid segregation (GO:0033045) | 3.25515522 |
| 63 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.25515522 |
| 64 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.25515522 |
| 65 | DNA replication checkpoint (GO:0000076) | 3.24562590 |
| 66 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21795469 |
| 67 | CENP-A containing nucleosome assembly (GO:0034080) | 3.21518662 |
| 68 | DNA strand elongation (GO:0022616) | 3.18475378 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.16168974 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.16168974 |
| 71 | glycine metabolic process (GO:0006544) | 3.14565494 |
| 72 | de novo protein folding (GO:0006458) | 3.10503624 |
| 73 | mitotic chromosome condensation (GO:0007076) | 3.08942536 |
| 74 | positive regulation of ligase activity (GO:0051351) | 3.08932704 |
| 75 | transcription from mitochondrial promoter (GO:0006390) | 3.08637424 |
| 76 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.05808284 |
| 77 | regulation of spindle organization (GO:0090224) | 3.04829673 |
| 78 | establishment of chromosome localization (GO:0051303) | 3.01970869 |
| 79 | maturation of 5.8S rRNA (GO:0000460) | 3.01326684 |
| 80 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.01041314 |
| 81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.01041314 |
| 82 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.00206772 |
| 83 | regulation of sister chromatid cohesion (GO:0007063) | 2.99238585 |
| 84 | regulation of gene silencing by RNA (GO:0060966) | 2.97380599 |
| 85 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.97380599 |
| 86 | regulation of gene silencing by miRNA (GO:0060964) | 2.97380599 |
| 87 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96759601 |
| 88 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96759601 |
| 89 | histone mRNA metabolic process (GO:0008334) | 2.96572162 |
| 90 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.95655388 |
| 91 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.94622230 |
| 92 | spindle checkpoint (GO:0031577) | 2.93576913 |
| 93 | COPII vesicle coating (GO:0048208) | 2.93487010 |
| 94 | nuclear envelope organization (GO:0006998) | 2.93117203 |
| 95 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.92905010 |
| 96 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.92905010 |
| 97 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.92905010 |
| 98 | mitotic sister chromatid segregation (GO:0000070) | 2.92840094 |
| 99 | mitotic spindle checkpoint (GO:0071174) | 2.92643170 |
| 100 | positive regulation of chromosome segregation (GO:0051984) | 2.92530900 |
| 101 | regulation of centrosome cycle (GO:0046605) | 2.92317529 |
| 102 | negative regulation of chromosome segregation (GO:0051985) | 2.92285397 |
| 103 | mitotic spindle assembly checkpoint (GO:0007094) | 2.92209730 |
| 104 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.91853872 |
| 105 | * G1/S transition of mitotic cell cycle (GO:0000082) | 2.91404071 |
| 106 | * cell cycle G1/S phase transition (GO:0044843) | 2.91404071 |
| 107 | regulation of translational fidelity (GO:0006450) | 2.90323827 |
| 108 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.90087939 |
| 109 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.90087939 |
| 110 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.90087939 |
| 111 | negative regulation of sister chromatid segregation (GO:0033046) | 2.90087939 |
| 112 | spliceosomal snRNP assembly (GO:0000387) | 2.89257591 |
| 113 | organelle disassembly (GO:1903008) | 2.88345138 |
| 114 | establishment of integrated proviral latency (GO:0075713) | 2.87272296 |
| 115 | chromatin remodeling at centromere (GO:0031055) | 2.87140189 |
| 116 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.86751728 |
| 117 | spindle assembly checkpoint (GO:0071173) | 2.85208745 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.83098407 |
| 119 | tRNA methylation (GO:0030488) | 2.82691847 |
| 120 | protein K11-linked ubiquitination (GO:0070979) | 2.82682630 |
| 121 | mitochondrial RNA metabolic process (GO:0000959) | 2.81800777 |
| 122 | negative regulation of DNA recombination (GO:0045910) | 2.80990823 |
| 123 | tetrahydrofolate metabolic process (GO:0046653) | 2.80514573 |
| 124 | de novo posttranslational protein folding (GO:0051084) | 2.80232817 |
| 125 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.80037195 |
| 126 | ventricular cardiac muscle cell development (GO:0055015) | 2.79556140 |
| 127 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.78053662 |
| 128 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.78053662 |
| 129 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.78053662 |
| 130 | tricarboxylic acid cycle (GO:0006099) | 2.77241895 |
| 131 | histone exchange (GO:0043486) | 2.77193475 |
| 132 | regulation of ligase activity (GO:0051340) | 2.76266479 |
| 133 | heterochromatin organization (GO:0070828) | 2.75834810 |
| 134 | single strand break repair (GO:0000012) | 2.74681140 |
| 135 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.73182097 |
| 136 | DNA geometric change (GO:0032392) | 2.72894601 |
| 137 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.72056844 |
| 138 | regulation of mitotic spindle organization (GO:0060236) | 2.71324822 |
| 139 | chromosome condensation (GO:0030261) | 2.71100993 |
| 140 | response to X-ray (GO:0010165) | 2.71086644 |
| 141 | DNA duplex unwinding (GO:0032508) | 2.70889901 |
| 142 | regulation of cofactor metabolic process (GO:0051193) | 2.70782879 |
| 143 | regulation of coenzyme metabolic process (GO:0051196) | 2.70782879 |
| 144 | protein localization to chromosome (GO:0034502) | 2.69050803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.81668118 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.54304725 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.64710309 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.34274634 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.25401822 |
| 6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.11918447 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.05797264 |
| 8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.03127773 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.99349565 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.97465073 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.95991897 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.92516470 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.90337085 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.86065966 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.80678106 |
| 16 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.73337719 |
| 17 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.61934891 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.49014300 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.45036131 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.42838361 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.42459824 |
| 22 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33697533 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.31127557 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28461523 |
| 25 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.27675567 |
| 26 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.25477767 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.24226048 |
| 28 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23281963 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.11611953 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.11539053 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01795185 |
| 32 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.00135349 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.97684970 |
| 34 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.97114643 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96057920 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.95053137 |
| 37 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94507109 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.93371138 |
| 39 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.92613755 |
| 40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81618298 |
| 41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.76738358 |
| 42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.72126948 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.71883008 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.70966020 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68970190 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.68667885 |
| 47 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.68208661 |
| 48 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.64382437 |
| 49 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.63125826 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63023489 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.62492285 |
| 52 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.59420755 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.56755483 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.56745027 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.45526865 |
| 56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42750813 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41397158 |
| 58 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.41355383 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40384168 |
| 60 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.39142907 |
| 61 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.39099493 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38677317 |
| 63 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37965500 |
| 64 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36105243 |
| 65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35945092 |
| 66 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.34655271 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29897297 |
| 68 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.26573653 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25909458 |
| 70 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.24451129 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22657109 |
| 72 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21824733 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21813514 |
| 74 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.19310115 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18920157 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18714330 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18431938 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17970757 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16010432 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14258242 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.13382480 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12739385 |
| 83 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.11153881 |
| 84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10827678 |
| 85 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.10475968 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.10280954 |
| 87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09458212 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09447974 |
| 89 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09292739 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08809819 |
| 91 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08744974 |
| 92 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07404773 |
| 93 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.07383473 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07351721 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06851878 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06219351 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.05461700 |
| 98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.05461700 |
| 99 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.05461700 |
| 100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04679228 |
| 101 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03991959 |
| 102 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.02418005 |
| 103 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.02220048 |
| 104 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.99454677 |
| 105 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.99194879 |
| 106 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98923107 |
| 107 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.98229072 |
| 108 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97041098 |
| 109 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.96219773 |
| 110 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94852795 |
| 111 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.94706916 |
| 112 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93885049 |
| 113 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93520062 |
| 114 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93113685 |
| 115 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92950949 |
| 116 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92942781 |
| 117 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92579346 |
| 118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92379430 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92041548 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91166111 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89683562 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89611427 |
| 123 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89565038 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89259506 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89230480 |
| 126 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.87393562 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86462054 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81475614 |
| 129 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80428127 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.79892213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004957_abnormal_blastocyst_morpholog | 4.37843814 |
| 2 | MP0003123_paternal_imprinting | 4.31089907 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.94488178 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.84173731 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.78915576 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.53399725 |
| 7 | MP0008057_abnormal_DNA_replication | 3.40861114 |
| 8 | MP0003077_abnormal_cell_cycle | 2.91859476 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.72578457 |
| 10 | MP0001730_embryonic_growth_arrest | 2.54345885 |
| 11 | MP0006054_spinal_hemorrhage | 2.51095957 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.47260853 |
| 13 | MP0000749_muscle_degeneration | 2.46455619 |
| 14 | MP0008058_abnormal_DNA_repair | 2.36929339 |
| 15 | MP0000751_myopathy | 2.24275431 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.18610437 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.00345992 |
| 18 | MP0003941_abnormal_skin_development | 1.96397978 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.95989869 |
| 20 | MP0005451_abnormal_body_composition | 1.95958186 |
| 21 | MP0005623_abnormal_meninges_morphology | 1.89644071 |
| 22 | MP0006035_abnormal_mitochondrial_morpho | 1.88755134 |
| 23 | MP0003121_genomic_imprinting | 1.86368743 |
| 24 | MP0000537_abnormal_urethra_morphology | 1.83782828 |
| 25 | MP0004233_abnormal_muscle_weight | 1.81086088 |
| 26 | MP0000350_abnormal_cell_proliferation | 1.78362826 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.78280687 |
| 28 | MP0003890_abnormal_embryonic-extraembry | 1.75465608 |
| 29 | MP0001697_abnormal_embryo_size | 1.74850772 |
| 30 | MP0002269_muscular_atrophy | 1.70812452 |
| 31 | MP0010307_abnormal_tumor_latency | 1.68771202 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.66940607 |
| 33 | MP0003718_maternal_effect | 1.66629592 |
| 34 | MP0003221_abnormal_cardiomyocyte_apopto | 1.62132239 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 1.58973580 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.57410939 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.55277598 |
| 38 | MP0002080_prenatal_lethality | 1.54530984 |
| 39 | MP0001672_abnormal_embryogenesis/_devel | 1.53536494 |
| 40 | MP0005380_embryogenesis_phenotype | 1.53536494 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.46683762 |
| 42 | MP0002084_abnormal_developmental_patter | 1.45289297 |
| 43 | MP0003880_abnormal_central_pattern | 1.42640857 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.41698100 |
| 45 | MP0000358_abnormal_cell_content/ | 1.41502171 |
| 46 | MP0002085_abnormal_embryonic_tissue | 1.39802953 |
| 47 | MP0003984_embryonic_growth_retardation | 1.38864142 |
| 48 | MP0004272_abnormal_basement_membrane | 1.38224581 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.38118863 |
| 50 | MP0005266_abnormal_metabolism | 1.37200793 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.37193170 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.36398397 |
| 53 | MP0004858_abnormal_nervous_system | 1.34906344 |
| 54 | MP0004197_abnormal_fetal_growth/weight/ | 1.33850347 |
| 55 | MP0003122_maternal_imprinting | 1.32235636 |
| 56 | MP0004133_heterotaxia | 1.29739017 |
| 57 | MP0004270_analgesia | 1.29597437 |
| 58 | MP0009672_abnormal_birth_weight | 1.27396046 |
| 59 | MP0003119_abnormal_digestive_system | 1.25818115 |
| 60 | MP0009697_abnormal_copulation | 1.25245453 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.23075946 |
| 62 | MP0002736_abnormal_nociception_after | 1.22702548 |
| 63 | MP0003329_amyloid_beta_deposits | 1.19427706 |
| 64 | MP0000747_muscle_weakness | 1.18643795 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.16192091 |
| 66 | MP0005360_urolithiasis | 1.15513136 |
| 67 | MP0003786_premature_aging | 1.14485163 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.12323651 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.10878891 |
| 70 | MP0005365_abnormal_bile_salt | 1.07219166 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.06940538 |
| 72 | MP0001727_abnormal_embryo_implantation | 1.05332612 |
| 73 | MP0000647_abnormal_sebaceous_gland | 1.04873337 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.04499131 |
| 75 | MP0003385_abnormal_body_wall | 1.04449251 |
| 76 | MP0008260_abnormal_autophagy | 1.03433402 |
| 77 | MP0000759_abnormal_skeletal_muscle | 1.02362391 |
| 78 | MP0005083_abnormal_biliary_tract | 1.01572378 |
| 79 | MP0001915_intracranial_hemorrhage | 0.99778149 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.98742888 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 0.98717274 |
| 82 | MP0004087_abnormal_muscle_fiber | 0.96738719 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.96024320 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94917148 |
| 85 | MP0002009_preneoplasia | 0.94609564 |
| 86 | MP0002127_abnormal_cardiovascular_syste | 0.94263134 |
| 87 | MP0001529_abnormal_vocalization | 0.94186260 |
| 88 | MP0001145_abnormal_male_reproductive | 0.93858667 |
| 89 | MP0002063_abnormal_learning/memory/cond | 0.92595035 |
| 90 | MP0003937_abnormal_limbs/digits/tail_de | 0.92142913 |
| 91 | MP0003186_abnormal_redox_activity | 0.92002022 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.91755478 |
| 93 | MP0001243_abnormal_dermal_layer | 0.90141449 |
| 94 | MP0000733_abnormal_muscle_development | 0.89585869 |
| 95 | MP0001661_extended_life_span | 0.89384610 |
| 96 | MP0005332_abnormal_amino_acid | 0.89177628 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.87880733 |
| 98 | MP0005384_cellular_phenotype | 0.87551419 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.87081268 |
| 100 | MP0002210_abnormal_sex_determination | 0.86084059 |
| 101 | MP0004145_abnormal_muscle_electrophysio | 0.84078151 |
| 102 | MP0002060_abnormal_skin_morphology | 0.84040570 |
| 103 | MP0002160_abnormal_reproductive_system | 0.82955724 |
| 104 | MP0000604_amyloidosis | 0.82756586 |
| 105 | MP0002254_reproductive_system_inflammat | 0.82318748 |
| 106 | MP0002733_abnormal_thermal_nociception | 0.82069339 |
| 107 | MP0008438_abnormal_cutaneous_collagen | 0.81626132 |
| 108 | MP0002177_abnormal_outer_ear | 0.81524261 |
| 109 | MP0002184_abnormal_innervation | 0.80721527 |
| 110 | MP0000313_abnormal_cell_death | 0.80436730 |
| 111 | MP0002106_abnormal_muscle_physiology | 0.80377233 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.79603884 |
| 113 | MP0002972_abnormal_cardiac_muscle | 0.78225918 |
| 114 | MP0003646_muscle_fatigue | 0.77438057 |
| 115 | MP0005501_abnormal_skin_physiology | 0.76914823 |
| 116 | MP0009703_decreased_birth_body | 0.76410583 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.74498562 |
| 118 | MP0003861_abnormal_nervous_system | 0.74390215 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.73992220 |
| 120 | MP0000653_abnormal_sex_gland | 0.73118019 |
| 121 | MP0002163_abnormal_gland_morphology | 0.72510755 |
| 122 | MP0001191_abnormal_skin_condition | 0.70595971 |
| 123 | MP0002102_abnormal_ear_morphology | 0.70498798 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.70342510 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.69804821 |
| 126 | MP0005620_abnormal_muscle_contractility | 0.69537597 |
| 127 | MP0002796_impaired_skin_barrier | 0.68350260 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.68143235 |
| 129 | MP0002233_abnormal_nose_morphology | 0.68037771 |
| 130 | MP0001929_abnormal_gametogenesis | 0.67654946 |
| 131 | MP0001440_abnormal_grooming_behavior | 0.66680664 |
| 132 | MP0000013_abnormal_adipose_tissue | 0.66184298 |
| 133 | MP0005621_abnormal_cell_physiology | 0.66158166 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.65653430 |
| 135 | MP0001293_anophthalmia | 0.65534025 |
| 136 | MP0005410_abnormal_fertilization | 0.65347827 |
| 137 | MP0005187_abnormal_penis_morphology | 0.65073139 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.64693263 |
| 139 | MP0005330_cardiomyopathy | 0.64527818 |
| 140 | MP0000750_abnormal_muscle_regeneration | 0.64120205 |
| 141 | MP0003935_abnormal_craniofacial_develop | 0.64056565 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.64039060 |
| 143 | MP0004924_abnormal_behavior | 0.64039060 |
| 144 | MP0002751_abnormal_autonomic_nervous | 0.63364532 |
| 145 | MP0002019_abnormal_tumor_incidence | 0.62159765 |
| 146 | MP0010030_abnormal_orbit_morphology | 0.61685859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 4.49298590 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 4.30137775 |
| 3 | Abnormality of the labia minora (HP:0012880) | 4.23899358 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.15972051 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 4.13425744 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 4.12027231 |
| 7 | Ependymoma (HP:0002888) | 4.12023823 |
| 8 | Abnormality of glycolysis (HP:0004366) | 3.99276976 |
| 9 | Increased serum pyruvate (HP:0003542) | 3.99276976 |
| 10 | Colon cancer (HP:0003003) | 3.35119865 |
| 11 | Cerebral hypomyelination (HP:0006808) | 3.32486363 |
| 12 | Shoulder girdle muscle weakness (HP:0003547) | 3.30734532 |
| 13 | Termporal pattern (HP:0011008) | 3.16821942 |
| 14 | Insidious onset (HP:0003587) | 3.16821942 |
| 15 | Agnosia (HP:0010524) | 3.13752316 |
| 16 | Breast hypoplasia (HP:0003187) | 3.06546109 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.05410713 |
| 18 | Astrocytoma (HP:0009592) | 2.93808449 |
| 19 | Abnormality of the astrocytes (HP:0100707) | 2.93808449 |
| 20 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.84004049 |
| 21 | Degeneration of anterior horn cells (HP:0002398) | 2.80710916 |
| 22 | Abnormality of the anterior horn cell (HP:0006802) | 2.80710916 |
| 23 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.79522673 |
| 24 | Angiofibromas (HP:0010615) | 2.71010812 |
| 25 | Adenoma sebaceum (HP:0009720) | 2.71010812 |
| 26 | Hyperglycinemia (HP:0002154) | 2.70754075 |
| 27 | Carpal bone hypoplasia (HP:0001498) | 2.70738511 |
| 28 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.70696573 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.70696573 |
| 30 | Hyperalaninemia (HP:0003348) | 2.70696573 |
| 31 | Rhabdomyosarcoma (HP:0002859) | 2.70410451 |
| 32 | Progressive external ophthalmoplegia (HP:0000590) | 2.68568279 |
| 33 | Pelvic girdle muscle weakness (HP:0003749) | 2.68110499 |
| 34 | Abnormality of the lower motor neuron (HP:0002366) | 2.67688251 |
| 35 | Biliary tract neoplasm (HP:0100574) | 2.67501039 |
| 36 | Medulloblastoma (HP:0002885) | 2.61984452 |
| 37 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.59531641 |
| 38 | Single umbilical artery (HP:0001195) | 2.59531641 |
| 39 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.59531641 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.53880338 |
| 41 | Microglossia (HP:0000171) | 2.53536091 |
| 42 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.53286408 |
| 43 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.53286408 |
| 44 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.49482307 |
| 45 | Oral leukoplakia (HP:0002745) | 2.49125866 |
| 46 | Volvulus (HP:0002580) | 2.49003250 |
| 47 | Multiple enchondromatosis (HP:0005701) | 2.47612250 |
| 48 | Glioma (HP:0009733) | 2.45944374 |
| 49 | Abnormality of the umbilical cord (HP:0010881) | 2.41432611 |
| 50 | Delusions (HP:0000746) | 2.34327970 |
| 51 | Tetraparesis (HP:0002273) | 2.34168441 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.33089744 |
| 53 | Cholecystitis (HP:0001082) | 2.33089744 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 2.32063861 |
| 55 | Limb-girdle muscle atrophy (HP:0003797) | 2.30621397 |
| 56 | Proximal placement of thumb (HP:0009623) | 2.30281714 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.29258707 |
| 58 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.28811163 |
| 59 | Deviation of the thumb (HP:0009603) | 2.28782338 |
| 60 | Embryonal renal neoplasm (HP:0011794) | 2.28767799 |
| 61 | Chromsome breakage (HP:0040012) | 2.26485615 |
| 62 | Postnatal microcephaly (HP:0005484) | 2.25732024 |
| 63 | Poor suck (HP:0002033) | 2.24374617 |
| 64 | Abnormality of chromosome stability (HP:0003220) | 2.23853270 |
| 65 | Selective tooth agenesis (HP:0001592) | 2.23828866 |
| 66 | CNS hypomyelination (HP:0003429) | 2.21836443 |
| 67 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.21774310 |
| 68 | Increased serum lactate (HP:0002151) | 2.19147624 |
| 69 | Subaortic stenosis (HP:0001682) | 2.17853781 |
| 70 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.17853781 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.16103228 |
| 72 | Myoglobinuria (HP:0002913) | 2.15440394 |
| 73 | Delayed gross motor development (HP:0002194) | 2.14137997 |
| 74 | Cortical dysplasia (HP:0002539) | 2.13960607 |
| 75 | Pheochromocytoma (HP:0002666) | 2.12855957 |
| 76 | Abnormality of serum amino acid levels (HP:0003112) | 2.12356285 |
| 77 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.11631564 |
| 78 | Unilateral renal agenesis (HP:0000122) | 2.11415574 |
| 79 | Neck muscle weakness (HP:0000467) | 2.10709519 |
| 80 | Upper limb muscle weakness (HP:0003484) | 2.09211933 |
| 81 | Abnormal auditory evoked potentials (HP:0006958) | 2.08115566 |
| 82 | Neoplasm of the rectum (HP:0100743) | 2.08095421 |
| 83 | Palpitations (HP:0001962) | 2.08060866 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07963479 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.07151392 |
| 86 | Progressive muscle weakness (HP:0003323) | 2.06401157 |
| 87 | Impulsivity (HP:0100710) | 2.05851561 |
| 88 | Dysautonomia (HP:0002459) | 2.04118139 |
| 89 | Neuroendocrine neoplasm (HP:0100634) | 2.03993805 |
| 90 | Abnormal neuron morphology (HP:0012757) | 2.02379579 |
| 91 | Abnormality of the motor neurons (HP:0002450) | 2.02379579 |
| 92 | Impaired pain sensation (HP:0007328) | 2.01782154 |
| 93 | Abnormality of pain sensation (HP:0010832) | 2.01782154 |
| 94 | Premature ovarian failure (HP:0008209) | 2.01316387 |
| 95 | EMG: myopathic abnormalities (HP:0003458) | 2.01267025 |
| 96 | Emotional lability (HP:0000712) | 2.00639323 |
| 97 | Unsteady gait (HP:0002317) | 1.99456050 |
| 98 | Rhabdomyolysis (HP:0003201) | 1.98259278 |
| 99 | Neoplasm of the small intestine (HP:0100833) | 1.98187654 |
| 100 | Limb-girdle muscle weakness (HP:0003325) | 1.97982446 |
| 101 | Abnormal biliary tract morphology (HP:0012440) | 1.97456430 |
| 102 | CNS demyelination (HP:0007305) | 1.97378356 |
| 103 | Abnormal lung lobation (HP:0002101) | 1.97025526 |
| 104 | Orthostatic hypotension (HP:0001278) | 1.96585228 |
| 105 | Visual hallucinations (HP:0002367) | 1.96386107 |
| 106 | Intestinal polyposis (HP:0200008) | 1.95276276 |
| 107 | Neoplasm of the pancreas (HP:0002894) | 1.94706850 |
| 108 | Rimmed vacuoles (HP:0003805) | 1.94564420 |
| 109 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.94475317 |
| 110 | Increased CSF lactate (HP:0002490) | 1.93086564 |
| 111 | Aplastic anemia (HP:0001915) | 1.92002020 |
| 112 | Thyroid carcinoma (HP:0002890) | 1.90313276 |
| 113 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90223946 |
| 114 | Patellar aplasia (HP:0006443) | 1.90196800 |
| 115 | Neoplasm of the colon (HP:0100273) | 1.89580527 |
| 116 | Neuroblastic tumors (HP:0004376) | 1.89237502 |
| 117 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.89237502 |
| 118 | Neuroblastoma (HP:0003006) | 1.89237502 |
| 119 | Primitive neuroectodermal tumor (HP:0030065) | 1.89237502 |
| 120 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.88941495 |
| 121 | Neoplasm of striated muscle (HP:0009728) | 1.87220491 |
| 122 | Megaloblastic anemia (HP:0001889) | 1.87098616 |
| 123 | Tetraplegia (HP:0002445) | 1.86298367 |
| 124 | Gout (HP:0001997) | 1.86202971 |
| 125 | Hypokinesia (HP:0002375) | 1.86083596 |
| 126 | Hyperglycinuria (HP:0003108) | 1.85927055 |
| 127 | Secondary amenorrhea (HP:0000869) | 1.85816023 |
| 128 | Cerebral edema (HP:0002181) | 1.85700379 |
| 129 | Athetosis (HP:0002305) | 1.85105063 |
| 130 | Resting tremor (HP:0002322) | 1.84100828 |
| 131 | Intestinal polyp (HP:0005266) | 1.83770914 |
| 132 | Spastic diplegia (HP:0001264) | 1.82939452 |
| 133 | Ovarian neoplasm (HP:0100615) | 1.82790943 |
| 134 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81849577 |
| 135 | Urinary urgency (HP:0000012) | 1.81644989 |
| 136 | Personality changes (HP:0000751) | 1.80325072 |
| 137 | Delayed puberty (HP:0000823) | 1.79709284 |
| 138 | Papillary thyroid carcinoma (HP:0002895) | 1.79019978 |
| 139 | Hypolipoproteinemia (HP:0010981) | 1.78179271 |
| 140 | Areflexia of lower limbs (HP:0002522) | 1.77109600 |
| 141 | Absent radius (HP:0003974) | 1.76756412 |
| 142 | Premature rupture of membranes (HP:0001788) | 1.76131638 |
| 143 | Microvesicular hepatic steatosis (HP:0001414) | 1.75883700 |
| 144 | Increased connective tissue (HP:0009025) | 1.75854920 |
| 145 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.75650878 |
| 146 | Neoplasm of the adrenal gland (HP:0100631) | 1.75615294 |
| 147 | Abnormality of glycine metabolism (HP:0010895) | 1.75190870 |
| 148 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.75190870 |
| 149 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.75013659 |
| 150 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.74985024 |
| 151 | Overlapping toe (HP:0001845) | 1.74961111 |
| 152 | Neoplasm of the oral cavity (HP:0100649) | 1.74705380 |
| 153 | Supernumerary spleens (HP:0009799) | 1.73295694 |
| 154 | Rough bone trabeculation (HP:0100670) | 1.73263083 |
| 155 | Ragged-red muscle fibers (HP:0003200) | 1.72297265 |
| 156 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70641752 |
| 157 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.70641752 |
| 158 | Autoamputation (HP:0001218) | 1.68932651 |
| 159 | Increased nuchal translucency (HP:0010880) | 1.68868461 |
| 160 | Long clavicles (HP:0000890) | 1.68748821 |
| 161 | Calcaneovalgus deformity (HP:0001848) | 1.67811366 |
| 162 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.67317744 |
| 163 | Proximal amyotrophy (HP:0007126) | 1.65265910 |
| 164 | Horizontal nystagmus (HP:0000666) | 1.63763717 |
| 165 | Distal lower limb amyotrophy (HP:0008944) | 1.62803135 |
| 166 | Abnormality of placental membranes (HP:0011409) | 1.62675032 |
| 167 | Amniotic constriction ring (HP:0009775) | 1.62675032 |
| 168 | Abnormality of the preputium (HP:0100587) | 1.61173560 |
| 169 | Breast carcinoma (HP:0003002) | 1.60352770 |
| 170 | Narrow face (HP:0000275) | 1.59552817 |
| 171 | Entropion (HP:0000621) | 1.56985678 |
| 172 | Hypoalphalipoproteinemia (HP:0003233) | 1.56939398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.92126613 |
| 2 | NEK1 | 3.75729091 |
| 3 | WEE1 | 3.60957571 |
| 4 | EIF2AK1 | 3.59066286 |
| 5 | TSSK6 | 3.22502521 |
| 6 | TRIM28 | 3.07223508 |
| 7 | CDC7 | 3.03430833 |
| 8 | LATS1 | 2.57853590 |
| 9 | ERBB3 | 2.48722406 |
| 10 | ACVR1B | 2.48036481 |
| 11 | SCYL2 | 2.39528465 |
| 12 | PNCK | 2.33710430 |
| 13 | AKT3 | 2.23189440 |
| 14 | PLK3 | 2.03766808 |
| 15 | PDK3 | 1.88886672 |
| 16 | PDK4 | 1.88886672 |
| 17 | MAP3K9 | 1.85563123 |
| 18 | MST4 | 1.85271537 |
| 19 | TTK | 1.83723843 |
| 20 | EIF2AK3 | 1.81886687 |
| 21 | LATS2 | 1.66202753 |
| 22 | PLK1 | 1.59670655 |
| 23 | PLK2 | 1.56301183 |
| 24 | MINK1 | 1.51736169 |
| 25 | PASK | 1.51662973 |
| 26 | MARK1 | 1.51206231 |
| 27 | BCR | 1.49499151 |
| 28 | KSR1 | 1.45785345 |
| 29 | MAP3K4 | 1.45578172 |
| 30 | SRPK1 | 1.41071168 |
| 31 | BRSK2 | 1.40932307 |
| 32 | CCNB1 | 1.37721032 |
| 33 | BRAF | 1.37407758 |
| 34 | KSR2 | 1.34511268 |
| 35 | NTRK3 | 1.34252709 |
| 36 | MST1R | 1.33102358 |
| 37 | NEK2 | 1.28715675 |
| 38 | ARAF | 1.26141011 |
| 39 | AURKA | 1.25348664 |
| 40 | TESK2 | 1.22892492 |
| 41 | NEK9 | 1.19170687 |
| 42 | DAPK1 | 1.18970390 |
| 43 | BRSK1 | 1.15062721 |
| 44 | LIMK1 | 1.14516456 |
| 45 | EPHA2 | 1.14194772 |
| 46 | TAF1 | 1.13699167 |
| 47 | MKNK2 | 1.12830007 |
| 48 | SIK3 | 1.11842040 |
| 49 | BCKDK | 1.11827988 |
| 50 | STK38L | 1.10198190 |
| 51 | TAOK2 | 1.10159706 |
| 52 | PLK4 | 1.08366160 |
| 53 | BRD4 | 1.07510040 |
| 54 | TTN | 1.06410212 |
| 55 | CSNK1A1L | 0.98415883 |
| 56 | RAF1 | 0.97499370 |
| 57 | CHEK1 | 0.96044002 |
| 58 | ATR | 0.94504286 |
| 59 | STK3 | 0.94116358 |
| 60 | CSNK1G1 | 0.92767487 |
| 61 | MAP3K8 | 0.90708219 |
| 62 | CHEK2 | 0.88648883 |
| 63 | NME1 | 0.87661019 |
| 64 | BMPR2 | 0.86703224 |
| 65 | TGFBR1 | 0.85565235 |
| 66 | DYRK2 | 0.85062393 |
| 67 | MAP2K4 | 0.83673522 |
| 68 | RPS6KB2 | 0.82505452 |
| 69 | CDK14 | 0.78212960 |
| 70 | PDK2 | 0.77684038 |
| 71 | IRAK3 | 0.77223005 |
| 72 | CDK6 | 0.77095727 |
| 73 | MAP3K10 | 0.76917826 |
| 74 | STK10 | 0.75486823 |
| 75 | AURKB | 0.75290998 |
| 76 | MET | 0.74670143 |
| 77 | CASK | 0.73959375 |
| 78 | PRKCG | 0.72071111 |
| 79 | MAPKAPK3 | 0.70521427 |
| 80 | CSNK1E | 0.70227725 |
| 81 | CSNK2A2 | 0.69996653 |
| 82 | PRKCI | 0.69304837 |
| 83 | ALK | 0.68809023 |
| 84 | ATM | 0.67486813 |
| 85 | CDK18 | 0.66926391 |
| 86 | CDK7 | 0.66780843 |
| 87 | CDK2 | 0.66052052 |
| 88 | TESK1 | 0.65424498 |
| 89 | PAK6 | 0.63182107 |
| 90 | EPHA4 | 0.61315495 |
| 91 | DYRK3 | 0.61286331 |
| 92 | CDK15 | 0.61136908 |
| 93 | MAP3K5 | 0.60639226 |
| 94 | RPS6KA4 | 0.60422731 |
| 95 | CDK4 | 0.58044984 |
| 96 | MKNK1 | 0.55120125 |
| 97 | CDK1 | 0.54376132 |
| 98 | OBSCN | 0.53941539 |
| 99 | CDK11A | 0.52917506 |
| 100 | CLK1 | 0.52491775 |
| 101 | MELK | 0.52073217 |
| 102 | PHKG2 | 0.50491798 |
| 103 | PHKG1 | 0.50491798 |
| 104 | NME2 | 0.50413540 |
| 105 | CSNK1G2 | 0.50291706 |
| 106 | CSNK2A1 | 0.49768541 |
| 107 | STK16 | 0.49702131 |
| 108 | MOS | 0.49449691 |
| 109 | PTK2 | 0.48171439 |
| 110 | RPS6KB1 | 0.48052677 |
| 111 | PKN2 | 0.46685771 |
| 112 | YES1 | 0.46610983 |
| 113 | MAP3K12 | 0.46388578 |
| 114 | STK24 | 0.45781596 |
| 115 | DAPK2 | 0.45239887 |
| 116 | FGFR1 | 0.44178459 |
| 117 | EIF2AK2 | 0.43979786 |
| 118 | PBK | 0.43790352 |
| 119 | CDK9 | 0.43475459 |
| 120 | STK38 | 0.43071176 |
| 121 | MAP3K11 | 0.42908635 |
| 122 | FER | 0.42792174 |
| 123 | WNK3 | 0.42379619 |
| 124 | CSNK1G3 | 0.41946548 |
| 125 | PAK4 | 0.41717045 |
| 126 | PDGFRA | 0.40352208 |
| 127 | PRKD3 | 0.39987816 |
| 128 | STK4 | 0.39139917 |
| 129 | CDK8 | 0.38472911 |
| 130 | MAP2K7 | 0.37231857 |
| 131 | ERBB4 | 0.36418737 |
| 132 | MAP4K2 | 0.35686466 |
| 133 | MAP2K1 | 0.35551367 |
| 134 | GRK5 | 0.35225038 |
| 135 | AKT2 | 0.33261613 |
| 136 | NEK6 | 0.30881187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.36909729 |
| 2 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.62182236 |
| 3 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.29450856 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.26758262 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.21275202 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 3.02825943 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.95874114 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88542321 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.87084341 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69155123 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.60396667 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.40698503 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28745785 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 2.18232936 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.03314435 |
| 16 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.93886459 |
| 17 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.91550979 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.86665691 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85971938 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76718699 |
| 21 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.76459846 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.75266098 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.72445775 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.68746012 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.67482834 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53178899 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.53054534 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47017068 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.45804658 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39751521 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33851164 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22579203 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 1.18665716 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15379669 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15034694 |
| 36 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.14742815 |
| 37 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.13140680 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10917271 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.08377543 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07486100 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.07405044 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02703489 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00027174 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.95846258 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95701529 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.95256898 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95100244 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94339757 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93849183 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92816527 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91113212 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89447317 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89152378 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87213419 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.87211817 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86863208 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85636982 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85634534 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83996743 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82639823 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78889197 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76347319 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75789707 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75694635 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75467953 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75178772 |
| 67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73804510 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71308414 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69301608 |
| 70 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.66996869 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65374857 |
| 72 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64215931 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63168040 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56176557 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54707749 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54362617 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54015809 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.52336764 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51654575 |
| 80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50514720 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50335448 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50112342 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48399171 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.44843828 |
| 85 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44541365 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44380104 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.42596037 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41455463 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40962892 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40681632 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40448763 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.39598313 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.39487615 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39344523 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38836296 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38693082 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37516350 |
| 98 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37343408 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36897168 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36786610 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35327937 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35229077 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34463027 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33995502 |
| 105 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33772954 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32891436 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30600703 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30534472 |
| 109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29355913 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28637292 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28272326 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24699381 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.22775286 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.22071661 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20486065 |
| 116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20468368 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19964850 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19724333 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19415513 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19132647 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.18987841 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.18747351 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18149935 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17964066 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17019129 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16625361 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.15200326 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.14944464 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.14579298 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.13622892 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.12484887 |

